Peer-Reviewed Journal Details
Mandatory Fields
Thompson PM;Jahanshad N;Ching CRK;Salminen LE;Thomopoulos SI;Bright J;Baune BT;Bertolín S;Bralten J;Bruin WB;Bülow R;Chen J;Chye Y;Dannlowski U;de Kovel CGF;Donohoe G;Eyler LT;Faraone SV;Favre P;Filippi CA;Frodl T;Garijo D;Gil Y;Grabe HJ;Grasby KL;Hajek T;Han LKM;Hatton SN;Hilbert K;Ho TC;Holleran L;Homuth G;Hosten N;Houenou J;Ivanov I;Jia T;Kelly S;Klein M;Kwon JS;Laansma MA;Leerssen J;Lueken U;Nunes A;Neill JO;Opel N;Piras F;Piras F;Postema MC;Pozzi E;Shatokhina N;Soriano-Mas C;Spalletta G;Sun D;Teumer A;Tilot AK;Tozzi L;van der Merwe C;Van Someren EJW;van Wingen GA;Völzke H;Walton E;Wang L;Winkler AM;Wittfeld K;Wright MJ;Yun JY;Zhang G;Zhang-James Y;Adhikari BM;Agartz I;Aghajani M;Aleman A;Althoff RR;Altmann A;Andreassen OA;Baron DA;Bartnik-Olson BL;Marie Bas-Hoogendam J;Baskin-Sommers AR;Bearden CE;Berner LA;Boedhoe PSW;Brouwer RM;Buitelaar JK;Caeyenberghs K;Cecil CAM;Cohen RA;Cole JH;Conrod PJ;De Brito SA;de Zwarte SMC;Dennis EL;Desrivieres S;Dima D;Ehrlich S;Esopenko C;Fairchild G;Fisher SE;Fouche JP;Francks C;Frangou S;Franke B;Garavan HP;Glahn DC;Groenewold NA;Gurholt TP;Gutman BA;Hahn T;Harding IH;Hernaus D;Hibar DP;Hillary FG;Hoogman M;Hulshoff Pol HE;Jalbrzikowski M;Karkashadze GA;Klapwijk ET;Knickmeyer RC;Kochunov P;Koerte IK;Kong XZ;Liew SL;Lin AP;Logue MW;Luders E;Macciardi F;Mackey S;Mayer AR;McDonald CR;McMahon AB;Medland SE;Modinos G;Morey RA;Mueller SC;Mukherjee P;Namazova-Baranova L;Nir TM;Olsen A;Paschou P;Pine DS;Pizzagalli F;Rentería ME;Rohrer JD;Sämann PG;Schmaal L;Schumann G;Shiroishi MS;Sisodiya SM;Smit DJA;Sønderby IE;Stein DJ;Stein JL;Tahmasian M;Tate DF;Turner JA;van den Heuvel OA;van der Wee NJA;van der Werf YD;van Erp TGM;van Haren NEM;van Rooij D;van Velzen LS;Veer IM;Veltman DJ;Villalon-Reina JE;Walter H;Whelan CD;Wilde EA;Zarei M;Zelman V; ;
Translational Psychiatry
ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries.
Optional Fields
This review summarizes the last decade of work by the ENIGMA (Enhancing NeuroImaging Genetics through Meta Analysis) Consortium, a global alliance of over 1400 scientists across 43 countries, studying the human brain in health and disease. Building on large-scale genetic studies that discovered the first robustly replicated genetic loci associated with brain metrics, ENIGMA has diversified into over 50 working groups (WGs), pooling worldwide data and expertise to answer fundamental questions in neuroscience, psychiatry, neurology, and genetics. Most ENIGMA WGs focus on specific psychiatric and neurological conditions, other WGs study normal variation due to sex and gender differences, or development and aging; still other WGs develop methodological pipelines and tools to facilitate harmonized analyses of "big data" (i.e., genetic and epigenetic data, multimodal MRI, and electroencephalography data). These international efforts have yielded the largest neuroimaging studies to date in schizophrenia, bipolar disorder, major depressive disorder, post-traumatic stress disorder, substance use disorders, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, autism spectrum disorders, epilepsy, and 22q11.2 deletion syndrome. More recent ENIGMA WGs have formed to study anxiety disorders, suicidal thoughts and behavior, sleep and insomnia, eating disorders, irritability, brain injury, antisocial personality and conduct disorder, and dissociative identity disorder. Here, we summarize the first decade of ENIGMA's activities and ongoing projects, and describe the successes and challenges encountered along the way. We highlight the advantages of collaborative large-scale coordinated data analyses for testing reproducibility and robustness of findings, offering the opportunity to identify brain systems involved in clinical syndromes across diverse samples and associated genetic, environmental, demographic, cognitive, and psychosocial factors.
Grant Details
Publication Themes